Chiltern Launches Collaborative Technologies

LONDON, June 10, 2010 - Chiltern International Limited (Chiltern), a global contract research
organization (CRO), announced the launch of Collaborative Technologies.

"Chiltern's Collaborative Technologies is a turnkey solution reflecting
integrated processes and technology which offers a single access point to
clinical study data and the central document repository for the entire study
team. Our Data Warehousing brings together data from core clinical systems to
present one consolidated view of information," stated Dr Jim Esinhart,
Chiltern Executive Vice President, Global Biometrics and North America.

Glenn Kerkhof, Chiltern CEO, commented, "A key benefit of Collaborative
Technologies is the immediate access to current study information which the
entire study team can access wherever they are located globally. This means
faster decisions can be made on the study which results in time and cost
savings for our clients."

Dr Esinhart added, "In addition to the core components in the
Collaborative Technologies platform, it has been configured to work with
Chiltern's proprietary systems such as Chiltern Insight, our clinical trial
management system, and Chiltern Safe, our Trial Master File and Electronic
Records Management system. We are extremely pleased to report that
Collaborative Technologies works hand-in-hand with our industry's leading
systems such as Medidata Rave(R) and Clinphone Datalabs(R) for Electronic
Data Capture (EDC), Phase Forward's Empirica(TM) Trace for adverse event
management and endpoint's PULSE for Interactive Response Technology (IRT). To
summarize, Collaborative Technologies offers our clients a suite of
best-in-class technological solutions for their clinical trial needs under
one organization."

Company profile

About Chiltern:

Established in 1982, Chiltern is a leading global Contract Research
Organization with extensive experience conducting and staffing international
Phase I to Phase IV clinical trials across a broad range of therapeutic areas
for a wide variety of clients. Chiltern has conducted trials in more than 40
countries, has 24 offices and legal entities within 20 countries, resources
in 37 countries and employs nearly 1,400 people globally. Chiltern provides
Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and
Regulatory Affairs and Resourcing Solutions services. Further information:
www.chiltern.com.

    Contact:

    Natalie Chong, Marketing Director    Susan Ojanen, Marketing Associate
    Chiltern International Ltd.          Chiltern International Inc.
    171 Bath Road                        1241 Volunteer Parkway
    Slough                               Suite 950
    Berkshire SL1 4AA                    Bristol, TN 37620
    UNITED KINGDOM                       USA
    Tel:  +44-(0)-1753-512-000           Tel:  +1-423-968-9533
    natalie.chong@chiltern.com           susan.ojanen@chiltern.com

Natalie Chong, Marketing Director, +44-(0)-1753-512-000, natalie.chong at chiltern.com, or Susan Ojanen, Marketing Associate, +1-423-968-9533, susan.ojanen at chiltern.com, both of Chiltern